1 Miller KM, Beck RW, Bergenstal RM, et al. Evidence of a strong association between frequency of self-monitoring of blood glucose and hemoglobin A1c levels in T1D exchange clinic registry participants. Diabetes Care 2013;36:2009–14.
2 Karter AJ, Ackerson LM, Darbinian JA, et al. Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente diabetes registry. Am J Med 2001;111:1–9.
3 Gagliardino J, Bergenstal R, Colagiuri S. IDF guideline on self- monitoring of blood glucose in non-insulin treated type 2 diabetes. Brussels: International Diabetes Federation, 2008.
4 Towfigh A, Romanova M, Weinreb JE, et al. Self-monitoring of blood glucose levels in patients with type 2 diabetes mellitus not taking insulin: a meta-analysis. Am J Manag Care 2008;14:468–75.
5 McIntosh B, Yu C, Lal A, et al. Efficacy of self-monitoring of blood glucose in patients with type 2 diabetes mellitus managed without insulin: a systematic review and meta-analysis. Open Med 2010;4:e102–13.
6 Schütt M, Kern W, Krause U, et al. Is the frequency of self- monitoring of blood glucose related to long-term metabolic control? Multicenter analysis including 24,500 patients from 191 centers in Germany and Austria. Exp Clin Endocrinol Diabetes 2006;114:384–8.
7 Davidson MB, Castellanos M, Kain D, et al. The effect of self monitoring of blood glucose concentrations on glycated hemoglobin levels in diabetic patients not taking insulin: a blinded, randomized trial. Am J Med 2005;118:422–5.
8 Guerci B, Drouin P, Grangé V, et al. Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance intervention active (ASIA) study. Diabetes Metab 2003;29:587–94.
9 Bolinder J, Antuna R, Geelhoed-Duijvestijn P, et al. Novel glucose- sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial. Lancet 2016;388:2254–63.
10 Dover AR, Stimson RH, Zammitt NN, et al. Flash glucose monitoring improves outcomes in a type 1 diabetes clinic. J Diabetes Sci Technol 2017;11:442–3.
11 Kramer G, Michalak L, Müller UA, et al. Association between flash glucose monitoring and metabolic control as well as treatment satisfaction in outpatients with diabetes type 1. Exp Clin Endocrinol Diabetes 2019. doi:10.1055/a-0875-3988. [Epub ahead of print: 11 Jun 2019].
12 Tyndall V, Stimson RH, Zammitt NN, et al. Marked improvement in HbA1c following commencement of flash glucose monitoring in people with type 1 diabetes. Diabetologia 2019;62:1349–56.
13 Paris I, Henry C, Pirard F, et al. The new FreeStyle libre flash glucose monitoring system improves the glycaemic control in a cohort of people with type 1 diabetes followed in real-life conditions over a period of one year. Endocrinol Diabetes Metab 2018;1:e00023.
14 Haak T, Hanaire H, Ajjan R, et al. Flash glucose-sensing technology as a replacement for blood glucose monitoring for the management of insulin-treated type 2 diabetes: a multicenter, open-label randomized controlled trial. Diabetes Ther 2017;8:55–73.
15 Yaron M, Roitman E, Aharon-Hananel G, et al. Effect of flash glucose monitoring technology on glycemic control and treatment satisfaction in patients with type 2 diabetes. Diabetes Care 2019;42:1178–84.
16 Ajjan RA, Jackson N, Thomson SA. Reduction in HbA1c using professional flash glucose monitoring in insulin-treated type 2 diabetes patients managed in primary and secondary care settings: a pilot, multicentre, randomised controlled trial. Diab Vasc Dis Res 2019;16:385–95.
17 Matsuo S, Imai E, Horio M, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009;53:982–92.
18 Haneda M, Noda M, Origasa H, et al. Japanese clinical practice guideline for diabetes 2016. Diabetol Int 2018;9:1–45.
19 American Diabetes Association. 6. Glycemic Targets: Standards of Medical Care in Diabetes-2019. Diabetes Care 2019;42:S61–70.
20 Bradley C, Gamsu DS. Guidelines for encouraging psychological well-being: report of a working group of the world Health organization regional office for Europe and international diabetes Federation European region St Vincent Declaration action programme for diabetes. Diabet Med 1994;11:510–6.
21 Ishii H. The Japanese Version of the Diabetes Treatment Satisfaction Questionnaire (DTSQ) : translation and clinical evaluation. J Clin Exp Med 2000;192:809–14.
22 Kovatchev BP, Clarke WL, Breton M, et al. Quantifying temporal glucose variability in diabetes via continuous glucose monitoring: mathematical methods and clinical application. Diabetes Technol Ther 2005;7:849–62.
23 McDonnell CM, Donath SM, Vidmar SI, et al. A novel approach to continuous glucose analysis utilizing glycemic variation. Diabetes Technol Ther 2005;7:253–63.
24 Clarke W, Kovatchev B. Statistical tools to analyze continuous glucose monitor data. Diabetes Technol Ther 2009;11(Suppl 1):S-45–54.
25 Arambepola C, Ricci-Cabello I, Manikavasagam P, et al. The impact of automated brief messages promoting lifestyle changes delivered via mobile devices to people with type 2 diabetes: a systematic literature review and meta-analysis of controlled trials. J Med Internet Res 2016;18:e86.
26 Orsama A-L, Lähteenmäki J, Harno K, et al. Active assistance technology reduces glycosylated hemoglobin and weight in individuals with type 2 diabetes: results of a theory-based randomized trial. Diabetes Technol Ther 2013;15:662–9.
27 Al Hayek AA, Robert AA, Al Dawish MA. Differences of FreeStyle Libre flash glucose monitoring system and finger pricks on clinical characteristics and glucose monitoring Satisfactions in type 1 diabetes using insulin pump. Clin Med Insights Endocrinol Diabetes 2019;12:117955141986110.
28 Saisho Y. Use of diabetes treatment satisfaction questionnaire in diabetes care: importance of patient-reported outcomes. Int J Environ Res Public Health 2018;15. doi:10.3390/ijerph15050947. [Epub ahead of print: 09 May 2018].